Nektar Therapeutics
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2010 | — | $90.7M | $17.8M |
| FY2011 | — | $197.8M | $15.3M |
| FY2012 | — | $47.0M | $25.4M |
| FY2013 | — | $-89.9M | $39.1M |
| FY2014 | — | $36.3M | $12.4M |
| FY2015 | — | $6.4M | $55.6M |
| FY2016 | — | $88.1M | $59.6M |
| FY2017 | — | $87.8M | $4.8M |
| FY2018 | — | $1.72B | $194.9M |
| FY2019 | — | $1.41B | $96.4M |